SCHEMBL1851645

SCHEMBL1851645

Cc1ccc(C(C)C(N)=O)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.42
ADRA2B P18089 2/20 0.42
ADRA2C P18825 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
PLAU P00749 1/20 0.42
NOS3 P29474 1/20 0.41
NOS2 P35228 1/20 0.41
CCR1 P32246 1/20 0.39
CCR5 P51681 1/20 0.39
CCR8 P51685 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
XIAP P98170 1/20 0.38
BIRC2 Q13490 1/20 0.38
ALOX5 P09917 1/20 0.36
EPHX1 P07099 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 3/20 0.35
HSD17B10 Q99714 1/20 0.35
PARP1 P09874 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27668674 0.85 RAB9A (0.48) ADRA2AADRA2BADRA2CMAPTRAB9A
SCHEMBL19716497 0.83 ADRA2A (0.43) ADRA2AADRA2BADRA2CMAPTRAB9A
SCHEMBL29658558 0.83 ADRA2A (0.43) ADRA2AADRA2BADRA2CMAPTRAB9A
SCHEMBL31240136 0.83 MAPT (0.43) ADRA2AADRA2BADRA2CMAPTRAB9A
SCHEMBL29457073 0.80 EPHX1 (0.42) MAPTRAB9AEPHX1KDM4EMEN1
SCHEMBL29457012 0.80 APLNR (0.54) HDAC6EPHX1APLNR
SCHEMBL29457086 0.80 PTK2 (0.42) ADRA2AADRA2BADRA2CRAB9APLAU
SCHEMBL17827994 0.79 RAB9A (0.43) MAPTRAB9ACCR1CCR5CCR8
SCHEMBL1852826 0.77 ADRA2A (0.39) ADRA2AADRA2BADRA2CMAPTRAB9A
SCHEMBL19738832 0.77 CACNA1I (0.46) ALOX5ALDH1A1KDM4EPARP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324028-A2 THERAPEUTIC AGENTS 414 AstraZeneca AB (SE) 2011-05-25 EP disclosed
WO-2010015849-A2 THERAPEUTIC AGENTS 414 ASTRAZENECA AB (SE) 2010-02-11 WO disclosed